Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 29;15(4):e0231815.
doi: 10.1371/journal.pone.0231815. eCollection 2020.

Inhibitory effect of a weight-loss Chinese herbal formula RCM-107 on pancreatic α-amylase activity: Enzymatic and in silico approaches

Affiliations

Inhibitory effect of a weight-loss Chinese herbal formula RCM-107 on pancreatic α-amylase activity: Enzymatic and in silico approaches

Shiqi Luo et al. PLoS One. .

Abstract

Reducing carbohydrates digestion by having a low glycaemic index (GI) foods has been linked to weight loss. Inhibiting related enzymes is an alternative way to decrease carbohydrate digestion. RCM-107 (Slimming Plus), an eight-herb formula that is modified from RCM-104, indicated significant weight-loss action in clinical trials. However, no published research has studied its mechanism of action on reducing carbohydrate absorption via suppressing the activities of porcine pancreatic alpha-amylase (PPA). In this paper, we used fluorescence PPA inhibition assay to investigate the inhibitory effects of RCM-107 and the individual herbs present in this herbal mixture on amylase activity. Subsequently, molecular docking predicted the key active compounds that may be responsible for the enzyme inhibition. According to our results, both the RCM-107 formula and several individual herbs displayed α-amylase inhibitory effects. Also, marginal synergistic effects of RCM-107 were detected. In addition, alisol B, (-)-epigallocatechin-3-gallate (EGCG) and plantagoside have been predicted as the key active compounds that may be responsible for the α-amylase inhibition effect of RCM-107 according to inter-residue contact analysis. Finally, Glu233, Gln63, His305, Asp300 and Tyr151 are predicted to be markers of important areas with which potential amylase inhibitors would interact. Therefore, our data has provided new knowledge on the mechanisms of action of the RCM-107 formula and its individual herbal ingredients for weight loss, in terms of decreasing carbohydrate digestion via the inhibition of pancreatic alpha-amylase.

PubMed Disclaimer

Conflict of interest statement

The authors have read the journal’s policy and the authors of this manuscript have the following competing interests to declare: Tong Kang Lee Chinese Medical Centre supported this study. However, this does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.

Figures

Fig 1
Fig 1. Suppressive effects of the RCM-107 formula, eight single herbal granules and acarbose (inhibitor) at 300 μg mL-1 on porcine pancreatic α-amylase activity.
The enzyme activity with an absence of the samples or inhibitor was presented as 100%. Data are expressed as means ± standard error of the mean (SEM) from three independent experiments, including three replicates each time. **** indicates P < 0.0001 as compared to the control.
Fig 2
Fig 2. Dose-dependent inhibitory effects of the RCM-107 formula (1–800μg mL-1) on porcine α-amylase.
Data represent mean ± SEM from three independent experiments with three replicates per condition.
Fig 3
Fig 3. 2D diagram of interactions between corn starch and 1OSE.
Fig 4
Fig 4. a-b. Chemical structures of selected compounds.
Fig 5
Fig 5
a. 2D diagram of top 3 predicted ligands from each herb with 1OSE. Hydrogen bonds (green circles with traced lines), van der Waals forces of attraction (light green circles), Pi-Alkyl interactions (pink circles with traced lines), Pi-Sigma interaction (purple circles with traced lines). 1) Acarbose (3 binding poses); 2). Stigmasterol. b. 3) Campesterol; 4) Cassiaside; 5) Theaflavin; 6) Thearubigin. c. 7) EGCG; 8) Cycloartenol; 9) Quercetin; 10) Isorhamnetin. d. 11) Beta-sitosterol; 12) N-[6-(acridin-9-ylamino) hexyl] benzamide; 13) Sophoradiol; 14) Sudan III. e. 15) Alisol B; 16) Alisol A. 17) Alisol C; 18) Stellasterol. f. 19) Eburicoic acid; 20) Dehydroeburicoic acid; 21) plantagoside; 22) Daucostero_qt.
Fig 6
Fig 6. 3D interactions between predicted leading compounds EGCG (pink), plantagoside (yellow), the known inhibitor acarbose (red) and 1OSE.

References

    1. Jastreboff AM, Kotz CM, Kahan S, Kelly AS, Heymsfield SB. Obesity as a disease: The obesity society 2018 position statement. Obesity. 2019;27(1): 7–9. 10.1002/oby.22378 . - DOI - PubMed
    1. Yan X, Zhang M, Wu T, Dai SD, Xu JL, Zhou ZK. The anti-obesity effect of green tea polysaccharides, polyphenols and caffeine in rats fed with a high-fat diet. Food Funct. 2015;6(1): 296–303. - PubMed
    1. Piche ME, Poirier P, Lemieux I, Despres JP. Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: An update. Prog Cardiovasc Dis. 2018;61(2): 103–13. 10.1016/j.pcad.2018.06.004 . - DOI - PubMed
    1. WHO. 10 Facts on obesity: WHO; 2019 [cited 2019 18 January]. https://www.who.int/features/factfiles/obesity/en/
    1. Tucci SA, Boyland EJ, Halford JC. The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: A review of current and emerging therapeutic agents. Diabetes Metab Syndr Obes. 2010;3: 125 10.2147/dmsott.s7005 - DOI - PMC - PubMed

Publication types

MeSH terms